Purchase Order 36C26121P0670
Award Date 3/16/21
Potential Completion Date 5/15/21
Potential Value $285K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA-VHA) awarded a $287,923.29 purchase order contract to Cardinal Health, Inc. for YESCARTA Therapy. As the prime contractor, Cardinal Health Inc. Division - doing business as Cardinal Health, will provide YESCARTA Therapy from August 18, 2022 through February 28, 2023 in Dublin, Ohio under firm fixed pricing terms. YESCARTA is a chimeric antigen receptor (CAR) T-cell immunotherapy...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for YESCARTA Drug. The contract has a period of performance from March 22, 2022 through March 28, 2022 and utilizes a firm fixed price pricing structure. Cardinal Health, Inc. will provide YESCARTA, a chimeric antigen receptor T-cell therapy, as the prime contractor.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for EMERGENCY-YESCARTA. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, will provide the products or services defined in the EMERGENCY-YESCARTA solicitation from their place of performance in Dublin, Ohio, between November 30, 2022 and December 2, 2022. The...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health, Inc. for the delivery of one treatment of the cancer drug YESCARTA. The contract has a firm fixed price of $284,904.52 and a completion date of May 28, 2021. As the prime contractor, Cardinal Health will leverage its expertise in nuclear pharmacy services and distribution capabilities to ensure reliable delivery of this essential radiopharmaceutical product to the VA...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $284,904.52 purchase order contract to Cardinal Health, Inc., doing business as Cardinal Health, for YESCART (AXICABTAGENE CILOLEUCEL INJ SUSP). The place of performance is Dublin, OH and the contract period is from November 30, 2021 to December 1, 2021. The pricing structure is firm fixed price. No subcontractors were identified.</p>
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $307,114.91 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for emergency TECARTUS infusion services. Cardinal Health, Inc. will provide these services as the prime contractor from April 25, 2023 through May 3, 2023 in Dublin, Ohio under a firm fixed price contract structure. No subcontractors were identified.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $307,114.91 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for EMERGENCY QTY 1 TECCARTUS. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, will provide the biopharmaceutical product Teccartus from its facility in Dublin, Ohio over a period of approximately three months, from September 13, 2023 through November 24,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for emergency order of Yescxart drugs in the quantity of one. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, Inc., will provide the drugs from its Dublin, Ohio facility between April 20, 2022 and April 26, 2022 under firm fixed pricing terms. No applicable...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a $201,917.38 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. Under this contract, Cardinal Health will provide nuclear medicine and radiology pharmaceuticals to the VA medical center in Dublin, Ohio, in support of diagnostic imaging and treatment services for...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a $132,000 firm fixed price delivery order for radiopharmaceuticals against the Veterans Health Administration Federal Supply Schedule. The contract has no set-aside designation and requires Cardinal Health to provide the specified products to the Veterans Integrated Service Network 15 in Dublin, Ohio, with performance through April 2026. As one of the largest healthcare services companies in the United States, Cardinal...
Cardinal Health, Inc. was awarded a $285,000 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to deliver YESCARTA (axicabtagene ciloleucel) injections for cancer treatment. As the prime contractor, Cardinal Health will provide the chimeric antigen receptor T-cell immunotherapy drug manufactured by Kite Pharma, Inc. from its manufacturing facility in Dublin, Ohio for administration to veterans through VA medical centers in the network's jurisdiction. The firm fixed price order is for supply of the treatment from March through May 2021 to support the VA's efforts to provide state-of-the-art therapies for cancer patients through its oncology and hematology programs.
Generated 12/29/23, 2:53 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--SpecialtyDrug - YESCARTA | 36C26121P0670 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Award Notice 1/1 | 4/13/21, 10:36 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $284.9k | 3/16/21 |